His research interests include: 1) developing novel nucleic acid technology for cancer diagnostics; 2) leveraging molecular phenotyping to identify and exploit therapeutic vulnerabilities in cancer. Previously, he worked at the McDonnell Genome Institute, where he contributed to publications in Nature Communications and Nature Genetics. In addition, he cofounded a bioengineering incubator (IDEA Labs, now Sling Health), and consults for a late-stage biotech startup in San Francisco. He received an MD from Washington University and a BS from Olin College of Engineering.